Gilles Pernod

Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban

Raphaël Marlu, Enkelejda Hodaj, Pierre Albaladéjo et al. · Thrombosis and Haemostasis · 2012 · 502 citations

Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach

David‐Alexandre Trégouët, Simon Heath, Noémie Saut et al. · Blood · 2009 · 315 citations

Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: Proposals of the Working Group on Perioperative Haemostasis (GIHP) – March 2013

Gilles Pernod, Pierre Albaladejo, Anne Godiér et al. · Archives of cardiovascular diseases · 2013 · 305 citations

Thrombosis, Direct Oral Anticoagulants, Cardiovascular Disease +15

Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism

Françis Couturaud, Olivier Sanchez, Gilles Pernod et al. · JAMA · 2015 · 233 citations · Full text

Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study

Marc Rodger, Grégoire Le Gal, David R. Anderson et al. · BMJ · 2017 · 232 citations · Full text